Ion Exchange FY26 net profit falls 31% to ₹1,432 crore

2 min read     Updated on 06 Jun 2026, 08:41 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Ion Exchange (India) Limited reported a 31% decline in FY26 consolidated net profit to ₹1,432 crore, impacted by exceptional costs from new Labour Codes, while revenue from operations grew. The board recommended a dividend of ₹1.25 per share. For Q4FY26, consolidated net profit was ₹243 crore, with the Engineering segment facing disruptions from the West Asia crisis and the Chemicals segment seeing margin pressure from input costs. The company announced strategic collaborations, including a technology transfer with MANN+HUMMEL for membrane technologies, and secured key certifications for its Roha facility.

powered bylight_fuzz_icon
40840216

*this image is generated using AI for illustrative purposes only.

Ion Exchange (India) Limited reported a 31% decline in consolidated net profit to ₹1,432 crore for FY26, down from ₹2,083 crore in the previous year, impacted by exceptional costs related to new Labour Codes. The board, which met on May 26, 2026, approved the audited financial results and recommended a dividend of ₹1.25 per equity share, subject to shareholder approval. The record date for the dividend has been fixed as August 31, 2026. The company submitted its earnings presentation for Q4FY26 and FY26 to the exchanges on May 29, 2026.

Annual Financial Performance

For the full year, standalone revenue from operations grew to ₹267,891 lakh from ₹254,006 lakh, while total standalone income reached ₹277,386 lakh. On a consolidated basis, the company reported a net profit of ₹14,321 lakh for FY26, with total income of ₹300,141 lakh. The statutory auditors issued an unmodified opinion on both the standalone and consolidated financial results. The meeting also addressed the impact of the new Labour Codes, which resulted in an exceptional item of ₹1,454 lakh in standalone results and ₹1,689 lakh in consolidated results due to increased gratuity and leave liabilities.

Metric Standalone FY26 (₹ in Lacs) Standalone FY25 (₹ in Lacs) Consolidated FY26 (₹ in Lacs) Consolidated FY25 (₹ in Lacs)
Revenue from Operations 267,891 254,006 291,484 273,711
Total Income 277,386 259,121 300,141 278,572
Net Profit 13,838 21,448 14,321 20,825
Basic EPS (₹) 11.26 17.45 12.03 17.53

Segment Performance

The Engineering segment led revenue generation, contributing ₹167,155 lakh in standalone revenue for the year, followed by the Chemicals segment at ₹71,800 lakh. The Consumer Products segment recorded revenue of ₹37,942 lakh. Consolidated revenue for the Engineering segment was ₹175,776 lakh, while the Chemicals segment reported ₹86,772 lakh. The board also approved the appointment of M/s. R. Nanabhoy & Co. as Cost Auditors for the financial year 2026-27.

Q4 Performance

For the quarter ended March 31, 2026, the company reported a consolidated net profit of ₹243 crore on operating income of ₹8,633 crore. On a standalone basis, net profit for Q4FY26 was ₹196 crore on operating income of ₹8,139 crore. The order book stood at ₹26,433 crore as of March 31, 2026, with a bid pipeline of ₹95,090 crore.

Strategic Updates

Management highlighted that the Engineering segment's quarterly revenue was ₹5,539 million, flat year-on-year, with an EBIT of ₹215 million. Planned dispatches to GCC geographies were impacted by disruptions from the West Asia crisis, though customer clearances were received post-quarter. The company successfully commissioned the raw water treatment plant for the IOCL Panipat Refinery project. It also entered into a technology transfer collaboration with MANN+HUMMEL for ultra-filtration membranes and membrane bioreactor technology to strengthen its portfolio.

The Chemicals segment reported quarterly revenue of ₹2,297 million, up 3% year-on-year, with an EBIT of ₹334 million. Profitability was affected by input cost increases and the Roha facility costs, though pricing actions have been initiated. The Roha facility received certification from the Water Quality Association, expected to enhance international market access. The Consumer Products division recorded revenue of ₹1,047 million, a 34% year-on-year increase, with a loss of ₹46 crore compared to ₹52 crore in the previous year.

Historical Stock Returns for Ion Exchange

1 Day5 Days1 Month6 Months1 Year5 Years
+0.50%-4.35%-19.30%-4.88%-38.88%+80.97%

How will the implementation of the new Labour Codes impact the company's cost structure and operating margins going forward?

What is the expected timeline for realizing revenue from the technology transfer collaboration with MANN+HUMMEL?

How will the company mitigate input cost inflation in the Chemicals segment following the initiated pricing actions?

Ion Exchange approves ESOS 2026 with 92.3% shareholder support

1 min read     Updated on 26 May 2026, 02:34 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Ion Exchange (India) Limited has received shareholder approval for its Employee Stock Option Scheme 2026 through a postal ballot, with all four resolutions securing over 92% of valid votes. The scheme encompasses employees of the company and its subsidiaries, including provisions for secondary share acquisition and trust funding. The voting process, overseen by scrutinizer CS Nirmal Gupta, saw participation from 435 members, including the promoter group and public institutions.

powered bylight_fuzz_icon
41283361

*this image is generated using AI for illustrative purposes only.

Ion Exchange (India) Limited has secured shareholder approval for its Employee Stock Option Scheme 2026 through a postal ballot process. The four special resolutions put to vote were passed with a requisite majority, receiving over 92% of valid votes in favour. The scheme covers employees of the company and its subsidiary companies, and includes provisions for secondary acquisition of shares and funding for the trust.

The e-voting period commenced on April 25, 2026, and concluded on May 24, 2026. CS Nirmal Gupta of GMJ & Associates was appointed as the scrutinizer to oversee the process. The results were declared on May 25, 2026, confirming the approval of all four resolutions.

Voting Results Summary

The resolutions sought approval for the ESOS 2026, the grant of options to subsidiary employees, secondary acquisition of shares via a trust route, and the provision of funds by the company for the trust to purchase its own shares. The detailed voting patterns are outlined below.

Resolution Description Votes In Favor Votes Against % In Favor % Against
Approval of ESOS 2026 5,81,27,312 48,54,616 92.29% 7.71%
Grant of options to subsidiary employees 5,81,27,204 48,53,339 92.29% 7.71%
Secondary acquisition of shares via Trust 5,81,27,992 48,52,551 92.30% 7.70%
Provision of money for purchase of shares 5,81,28,001 48,52,542 92.30% 7.70%

Shareholder Participation

A total of 435 members participated in the remote e-voting process. The cut-off date for determining eligibility was April 17, 2026. The promoter and promoter group cast 27,327,438 votes in favour of the resolutions, representing 100% of their polled votes. Public institutions and public non-institutions also participated, with the former casting 21,614,049 votes in favour and the latter 9,185,825 votes in favour for the first resolution.

The scrutinizer's report confirmed that the remote e-voting module was disabled by National Securities Depository Limited (NSDL) after the voting period ended. The votes were unblocked in the presence of independent witnesses, and the data was reconciled with the company's records. The detailed reports will be preserved by the Company Secretary.

Historical Stock Returns for Ion Exchange

1 Day5 Days1 Month6 Months1 Year5 Years
+0.50%-4.35%-19.30%-4.88%-38.88%+80.97%

How will the implementation of ESOS 2026 impact Ion Exchange's employee retention and talent acquisition strategies?

What is the expected dilution in existing shareholding percentage once the options are granted and exercised?

How will the company fund the trust for secondary acquisitions, and what effect will this have on its cash reserves?

More News on Ion Exchange

1 Year Returns:-38.88%